Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $8.44, but opened at $7.76. Oxford BioMedica shares last traded at $7.76, with a volume of 500 shares changing hands.
Oxford BioMedica Stock Down 8.1%
The business has a 50 day simple moving average of $8.11 and a 200-day simple moving average of $9.01.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Further Reading
- Five stocks we like better than Oxford BioMedica
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
- Palantir’s AIPCon Shows Why Customers Are Fueling the Bull Case
- Chewy’s Growth Engine Is Stronger Than the Market Thinks
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
